Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johnny Yang

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Molecular Oncology|December 11, 2023
SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinomaPatricia L Theard, Amanda J Linke, Nancy E Sealover, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
SOS2 regulates the threshold of mutant <i>EGFR</i>-dependent oncogenesisPatricia L Theard, Amanda J Linke, Nancy E Sealover, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 10, 2017
Preclinical absorption, distribution, metabolism, excretion and pharmacokinetics of a novel selective inhibitor of breast cancer resistance protein (BCRP)Mingxiang Liao, Bei-Ching Chuang, Qing Zhu, et al.
Innovations in Pharmacy|May 22, 2025
A Pilot Study of Hemoglobin A1C Levels in Patients with Type 2 Diabetes after Creation of a Patient Assistance Program Enrollment Committee at a Student-Run Free ClinicJohn D Salvemini, Gregory R Vance, Amanda Pham, et al.
Research in Social & Administrative Pharmacy : RSAP|September 29, 2022
Examining the context, logistics, and outcomes of food prescription programs: A scoping reviewAnne Cafer, Meagen Rosenthal, Parker Smith, et al.
Innovations in Pharmacy|October 13, 2025
The Patient Assistance Program Committee at the Jackson Free Clinic: Discussing the Need, Design, and ImplementationGregory R Vance, Johnny Yang, Nickhil Rugnath, et al.
Plastic and Reconstructive Surgery|September 5, 2024
Morphologic Differences between Normocephalic and Scaphocephalic Sagittal CraniosynostosisAlexander Velazquez, Michael S Lebhar, Johnny Yang, et al.
Cureus|March 8, 2024
Precision Population Cancer Medicine in Cancer of the Uterine Cervix: A Potential Roadmap to Eradicate Cervical CancerMary R Nittala, Johnny Yang, Alexander E Velazquez, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 9, 2020
Biotransformation Pathways and Metabolite Profiles of Oral [<sup>14</sup>C]Alisertib (MLN8237), an Investigational Aurora A Kinase Inhibitor, in Patients with Advanced Solid TumorsSandeepraj Pusalkar, Xiaofei Zhou, Yuexian Li, et al.
Cancer Chemotherapy and Pharmacology|October 9, 2013
Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinaseSanthosh Palani, Mayankbhai Patel, Jessica Huck, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Molecular Oncology|December 11, 2023
SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinomaPatricia L Theard, Amanda J Linke, Nancy E Sealover, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
SOS2 regulates the threshold of mutant <i>EGFR</i>-dependent oncogenesisPatricia L Theard, Amanda J Linke, Nancy E Sealover, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 10, 2017
Preclinical absorption, distribution, metabolism, excretion and pharmacokinetics of a novel selective inhibitor of breast cancer resistance protein (BCRP)Mingxiang Liao, Bei-Ching Chuang, Qing Zhu, et al.
Innovations in Pharmacy|May 22, 2025
A Pilot Study of Hemoglobin A1C Levels in Patients with Type 2 Diabetes after Creation of a Patient Assistance Program Enrollment Committee at a Student-Run Free ClinicJohn D Salvemini, Gregory R Vance, Amanda Pham, et al.
Research in Social & Administrative Pharmacy : RSAP|September 29, 2022
Examining the context, logistics, and outcomes of food prescription programs: A scoping reviewAnne Cafer, Meagen Rosenthal, Parker Smith, et al.
Innovations in Pharmacy|October 13, 2025
The Patient Assistance Program Committee at the Jackson Free Clinic: Discussing the Need, Design, and ImplementationGregory R Vance, Johnny Yang, Nickhil Rugnath, et al.
Plastic and Reconstructive Surgery|September 5, 2024
Morphologic Differences between Normocephalic and Scaphocephalic Sagittal CraniosynostosisAlexander Velazquez, Michael S Lebhar, Johnny Yang, et al.
Cureus|March 8, 2024
Precision Population Cancer Medicine in Cancer of the Uterine Cervix: A Potential Roadmap to Eradicate Cervical CancerMary R Nittala, Johnny Yang, Alexander E Velazquez, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 9, 2020
Biotransformation Pathways and Metabolite Profiles of Oral [<sup>14</sup>C]Alisertib (MLN8237), an Investigational Aurora A Kinase Inhibitor, in Patients with Advanced Solid TumorsSandeepraj Pusalkar, Xiaofei Zhou, Yuexian Li, et al.
Cancer Chemotherapy and Pharmacology|October 9, 2013
Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinaseSanthosh Palani, Mayankbhai Patel, Jessica Huck, et al.
Pageof 3